CAS NO: | 1020149-73-8 |
包装 | 价格(元) |
10 mM * 1 mL in DMSO | 电议 |
10mg | 电议 |
50mg | 电议 |
100mg | 电议 |
200mg | 电议 |
生物活性 | SGI-1027 is aDNA methyltransferase(DNMT)inhibitor, withIC50s of 7.5 μM, 8 μM, and 12.5 μM for DNMT3B, DNMT3A, andDNMT1with poly(dI-dC) as substrate. | ||||||||||||||||
IC50& Target[1] |
| ||||||||||||||||
体外研究 (In Vitro) | SGI-1027 is a DNMT inhibitor, with IC50s of 7.5 μM, 8 μM, and 12.5 μM for DNMT3B, DNMT3A, and DNMT1 with poly(dI-dC) as substrate. SGI-1027 shows an IC50of 6 μM for DNMT1 (hemimethylated DNA). SGI-1027 (1, 2.5, or 5 μM) causes selective degradation of DNMT1 in several human cancer cell lines, but shows little or no cytotoxic effect on rat hepatoma cells, and does not induce apoptosis in rat hepatoma cells[1]. SGI-1027 shows an EC50of 0.9 μM for hDNMT3A, and causes cytotoxicity on KG-1 cells, with an EC50of 4.4 μM[2]. | ||||||||||||||||
分子量 | 461.52 | ||||||||||||||||
性状 | Solid | ||||||||||||||||
Formula | C27H23N7O | ||||||||||||||||
CAS 号 | 1020149-73-8 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 |
| ||||||||||||||||
溶解性数据 | In Vitro: DMSO : 27 mg/mL(58.50 mM;Need ultrasonic and warming) 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 In Vivo: 请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照In Vitro方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用;
以下溶剂前显示的百
|